Literature DB >> 26567475

ROR1-based immunomagnetic protocol allows efficient separation of CLL and healthy B cells.

Jana Kotašková1,2,3, Šárka Pavlová2,3, Igor Greif1, Olga Stehlíková2, Karla Plevová1,2,3, Pavlína Janovská1, Yvona Brychtová4, Michael Doubek3,4, Šárka Pospíšilová2,3, Vítězslav Bryja5,6.   

Abstract

Entities:  

Keywords:  ROR1; cell isolation; chronic lymphocytic leukaemia; complete remission

Mesh：

Substances：

Year:  2015        PMID： 26567475     DOI： 10.1111/bjh.13848

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.

Authors:  Pavlína Janovská; Vítězslav Bryja
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

2.  RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

Authors:  Tomasz Radaszkiewicz; Michaela Nosková; Kristína Gömöryová; Olga Vondálová Blanářová; Katarzyna Anna Radaszkiewicz; Markéta Picková; Ráchel Víchová; Tomáš Gybeľ; Karol Kaiser; Lucia Demková; Lucia Kučerová; Tomáš Bárta; David Potěšil; Zbyněk Zdráhal; Karel Souček; Vítězslav Bryja
Journal:  Elife       Date:  2021-10-27       Impact factor: 8.140

3.  Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia.

Authors:  Hana Plešingerová; Pavlína Janovská; Archana Mishra; Lucie Smyčková; Lucie Poppová; Antonín Libra; Karla Plevová; Petra Ovesná; Lenka Radová; Michael Doubek; Šárka Pavlová; Šárka Pospíšilová; Vítězslav Bryja
Journal:  Haematologica       Date:  2017-11-09       Impact factor: 9.941

4.  Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.

Authors:  Jitka Malcikova; Sarka Pavlova; Barbara Kunt Vonkova; Lenka Radova; Karla Plevova; Jana Kotaskova; Karol Pal; Barbara Dvorackova; Marcela Zenatova; Jakub Hynst; Eva Ondrouskova; Anna Panovska; Yvona Brychtova; Kristyna Zavacka; Boris Tichy; Nikola Tom; Jiri Mayer; Michael Doubek; Sarka Pospisilova
Journal:  Blood       Date:  2021-12-23       Impact factor: 25.476
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.